Zhongshan Ophthalmic Stem Cell Therapy: What are the successful cases and effects?
As a new therapeutic method, stem cell therapy has attracted extensive attention in the medical field. Zhongshan Ophthalmology Department, as a hospital focusing on the treatment of ophthalmic diseases, has also actively tried stem cell therapy and achieved some successful cases. Next, we will elaborate on the stem cell therapy in Zhongshan Ophthalmology Department from four aspects: treatment indications, treatment process, efficacy evaluation and potential risks.
Indications for treatment
The indications for stem cell therapy in Zhongshan Ophthalmology Department mainly include retinal diseases, corneal diseases and ocular surface diseases. In terms of retinal diseases, including macular degeneration, retinal pigment epithelial diseases, etc. In corneal diseases, including Sjogren's syndrome, keratitis, etc. In ocular surface diseases, including dry eye, conjunctivitis, etc. These diseases are common indications for stem cell therapy in Zhongshan Ophthalmology Department.
Zhongshan Ophthalmology Department adopts the method of autologous stem cell therapy, that is, stem cells are extracted from the patient's own body, and then injected into the patient's part that needs treatment after treatment. Therefore, stem cell therapy has good biocompatibility and safety, and is suitable for patients of all ages.
Treatment process
The treatment process of stem cell therapy in Zhongshan Ophthalmology Department mainly includes three steps: stem cell collection, treatment and injection.
First, doctors will collect stem cells from patients, usually through bone marrow puncture or fat extraction. Subsequently, the stem cells collected will go through a series of processing steps, including isolation, proliferation and activation. Finally, the treated stem cells will be injected into the patient's eyes where they need treatment.
The whole treatment process generally needs to be completed in the hospital, and each step needs professional medical personnel to operate. The safety and effectiveness of the treatment process have been strictly monitored and controlled.
Efficacy evaluation
The efficacy evaluation of stem cell therapy in Zhongshan Ophthalmology Department is mainly based on the degree of symptom relief and the results of eye examination.
In the treatment of retinal diseases, stem cell therapy can significantly improve the vision of patients and reduce the degree of retinopathy. In the treatment of corneal diseases, stem cell therapy can improve the transparency and stability of the cornea. In the treatment of ocular surface diseases, stem cell therapy can improve the dry eye and inflammatory symptoms of patients.
The efficacy evaluation after treatment generally needs to be carried out in weeks or months after treatment to evaluate the durability and stability of the treatment effect.
potential risk
The potential risks of stem cell therapy in Zhongshan Ophthalmology Department mainly include local injection site discomfort, infection and immune rejection.
Because stem cell therapy needs to be injected into the patient's eye, it may cause discomfort at the local injection site. In addition, if the operation is not standardized or the postoperative care is not in place, it may cause the risk of infection. At the same time, because the stem cells come from the patients themselves, the risk of immune rejection is low, but it is still possible to have an immune response.
Therefore, before stem cell therapy, Zhongshan Ophthalmology Department will conduct a detailed assessment and screening of patients to ensure patient safety and treatment effect.
Summary
Zhongshan ophthalmic stem cell therapy has achieved certain success in the treatment of ophthalmic diseases. The treatment indications are wide, the treatment process is safe and controllable, the efficacy evaluation is scientific and accurate, and the potential risks can be controlled. However, stem cell therapy is still in the exploratory stage, and further research and clinical practice are needed. It is hoped that Zhongshan Ophthalmology Department and more medical institutions can increase the research on stem cell therapy and provide better treatment methods for more patients with eye diseases.
